PRINCETON, NJ--(Marketwire - July 08, 2008) - Agile Therapeutics, Inc., today announced the appointment of Jeffrey Frick as Chief Business Officer. In his role, Mr. Frick will be responsible for leading the commercialization of Agile's low-dose contraceptive patch in late-stage clinical development and working with Agile's leadership team to prioritize and expand the company's women's health product pipeline.
